Description

Bloating and distension outcomes from the synbiotic trial are presented, showing symptom trajectories across study visits.

Figure 11

Chart

Source Paper

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …

Nutrients (2020)

PMID: 32635661

DOI: 10.3390/nu12071999

Cite This Figure

![Figure 11: Bloating and distension outcomes from the synbiotic trial are presented, showing symptom trajectories across study visits.]()

> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)

<figure>
  <img src="" alt="Bloating and distension outcomes from the synbiotic trial are presented, showing symptom trajectories across study visits." />
  <figcaption>Figure 11. Bloating and distension outcomes from the synbiotic trial are presented, showing symptom trajectories across study visits.<br>  Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption>
</figure>

Preuves associées

Bifidobacterium longum pour Irritable Bowel Syndrome (IBS)

Note B · 4 études

Galactooligosaccharides (GOS) pour Irritable Bowel Syndrome (IBS)

Note B · 3 études

Lactobacillus acidophilus pour Irritable Bowel Syndrome (IBS)

Note B · 3 études

Fructooligosaccharides (FOS) pour Irritable Bowel Syndrome (IBS)

Note D · 2 études